Bind Therapeutics and its treatment for treatment for non-small cell lung cancer may soon be owned by one-time partner Pfizer.
Bind, which filed for Chapter 11 bankruptcy in May, asked the bankruptcy court on July 1 to approve a stalking-horse bid... Read more »
A new workshop opened last week in New York where developers can fine- tune their blockchain software.
IBM has set up a Bluemix Garage in SoHo within a Galvanize campus that also just opened in town. The “garage” is a place... Read more »
Bristol-Myers Squibb has acquired cancer and rare disease drug developer Cormorant Pharmaceuticals, a deal that includes an early-stage cancer compound that could complement the way Bristol’s own immune-oncology treatments work.
New York-based Bristol (NYSE: BMY) said Tuesday that it has... Read more »
Here we are at the midpoint of 2016 already. Time to look back on the past six months—and some of the top stories of the year so far.
The following represent a cross-section of what Xconomy offers on a daily basis:... Read more »
The word of the week was “moonshot,” as U.S. Vice President Joe Biden’s cancer initiative convened a summit in Washington, DC. At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said... Read more »
As part of a national cancer “moonshot” initiative led by Vice President Joe Biden, the FDA said Wednesday it would retool the way it evaluates cancer treatments and tests.
But to what end?
The goals of the FDA’s new Oncology Center... Read more »
Inside our bodies, our cells move around, communicate, form new tissue, and heal wounds with the help of proteins called integrins. But when disease occurs, integrins get the wrong cues and do damage—they might help tumors grow, or promote inflammation or... Read more »
Reflexion Health, a San Diego startup founded in 2012 at the nonprofit West Health Institute, is moving to commercialize Vera, its physical rehabilitation system based on Microsoft Kinect’s motion tracking technology.
After recently raising $18 million in Series B funding, the... Read more »
Moderna Therapeutics still hasn’t produced data in humans supporting its technology, which is meant to turn our bodies into little drugmaking factories. But the Cambridge, MA-based company nonetheless keeps grabbing the attention, and cash, of other drugmakers.
Moderna said today that... Read more »
Modern Meadow, a New York-based company that has developed a method of turning living cells into materials used to make leather that mimics animal hide, has received a $40 million Series B funding to begin manufacturing and commercializing its leather products.... Read more »
Every day it seems a new tech startup emerges to tap the keg of the spirits industry, especially on the consumer delivery side. The team at New York’s SevenFifty took on a different approach, however, trying to fix inefficiencies in the... Read more »
It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’... Read more »
Venture investors, as well as tech companies hesitant to try going public, were hanging on the outcome of communications software company Twilio’s IPO this week in hopes that it would signal a thaw in the mood on Wall Street for such... Read more »